Iturin: A Promising Cyclic Lipopeptide with Diverse Applications

Role of iturin from Bacillus velezensis DMW1 in suppressing growth and pathogenicity of Plectosphaerella cucumerina in tomato by reshaping the rhizosphere microbial communities

Plant-associated microbiomes play a crucial role in suppressing plant and soil pathogens. However, the mechanisms by which pathogen invasion influences the interaction between bacteria and fungi remain unknown and warrant further investigation. In this study, Bacillus spp. was found to be more abundant in diseased rhizosphere in the presence of the soil-borne fungus Plectosphaerella cucumerina. Most of the isolated Bacillus spp. exhibited a robust ability to balance reactive oxygen species (ROS) and demonstrated broad-spectrum antagonistic activity against P. cucumerina, Phytophthora capsica, Fusarium oxysporum, and Ralstonia solanacearum. The secondary metabolite iturin was identified as the key antifungal compound produced by the representative strain Bacillus velezensis DMW1, which effectively inhibits fungal growth and disrupts cell structures. Transcriptome analysis revealed that fungi treated with iturin (28.67 µg/mL) exhibited 4995 differentially expressed genes (DEGs), including 2611 upregulated genes and 2384 downregulated genes, compared to the control group. Furthermore, the application of DMW1 and return-deficient mutant (Δitu) significantly altered microbial diversity and enriched beneficial microorganisms in the rhizosphere soil. The overall findings highlight the potential of DMW1 as a promising biological agent for controlling soil-borne diseases. Its strong antimicrobial properties, ability to colonize host plants effectively, and capacity to reshape the soil microbiota make it a valuable resource for enhancing microbial ecosystems and providing long-term benefits to plants.

Exploring the antifungal potential of novel Bacillus siamensis RBN19 against Bipolaris oryzae infecting rice: in vitro and in silico studies

Survey conducted during February and May 2023 in the rice growing regions of Chengalpattu and Kanchipuram districts of Tamil Nadu, India, revealed that Chengalpattu district had brown spot incidence ranging from 10.6 % to 89 %. Maximum of 89 PDI (percent disease incidence) was observed in the farm of SRM College of Agricultural Sciences, Chengalpattu District, Tamil Nadu, India. The pathogen was isolated and subjected to morphological characterization. Sixty-five bacteria were isolated from the rhizosphere soil of various crop plants and screened for their antifungal activity against Bipolaris oryzae by dual culture assay. Among all the strains, RBN19 exhibited highest antifungal activity with up to 60 percent inhibition of mycelial growth over the control. In the agar well diffusion technique, 944 of RBN19 were very much effective in inhibiting mycelial growth up to an area of 944 mm2 compared to the control. Further, various antimicrobial compounds were detected in Gas Chromatography/Mass spectrometry Analysis. The effective isolates were identified as Bacillus siamensis RBN19 (OR673613), B. rugosus RBN11 (OR673612), B. subtilis RBN24 (OR673611) and RBN26 - Pseudomonas putida (OR673599). PCR screening in B. siamensis (RBN19) revealed the presence of maximum antimicrobial peptide (AMP) genes such as iturin -ituD, ipa14, surfactin - srfA, bacillomycin - bamC, Bacilysin - bacAB and Fengycin - fenCAE. Further, seed germination assay revealed that, B. siamensis (RBN19) promoted seed germination up to 98 % with a maximum growth of shoot (7.2 cm) and root (12.6 cm). In silico studies showed the availability of potential antimicrobial compounds and their inhibitory efficacy against pectin lyase of B. oryzae. Ethyl iso allocate, was the active metabolite with promising affinity towards the virulence protein, pectin lyase. The findings of the present study confirmed the antifungal potential and plant growth promoting potential of B. siamensis (RBN19) against B. oryzae. Further, in silico studies revealed the future prospects towards the development of a potential bioformulation.

Total Synthesis, Structure Elucidation, and Bioactivity Evaluation of the Cyclic Lipopeptide Natural Product Paenilipoheptin A

In this study, we further investigated the structure of the recently reported cyclic lipopeptide natural product paenilipoheptin A. Here, we disclose the first total synthesis of the compound, allowing for its complete structural assignment. The route developed employs automated SPPS, providing access to the compound in quantities suitable for antibacterial and antifungal testing. These studies unequivocally establish the stereochemical framework of paenilipoheptin A and further reveal that the compound possesses moderate activity against Gram-positive bacteria.

Bio-Based Surfactants and Biosurfactants: An Overview and Main Characteristics

Natural surfactants are surface-active molecules synthesized from renewable resources (i.e., plants, animals, or microorganisms) and possess properties comparable to conventional surfactants, making them an environmentally friendly potential alternative to petrochemical surfactants. Additionally, they exhibit biological properties such as anti-microbial properties, biodegradability, and less toxicity, allowing their use in everyday products with minimal risk to human health and the environment. Based on their mode of production, natural surfactants can be classified into first-generation or bio-based surfactants and second-generation or biosurfactants, although their definition may vary depending on the author in the literature. This review offers an extensive classification of bio-based surfactants and biosurfactants, focusing on their composition, natural sources, production methods, and potential applications across various industries. Furthermore, the main challenges and future perspectives are discussed.

Engineering of acyl ligase domain in non-ribosomal peptide synthetases to change fatty acid moieties of lipopeptides

Cyclic lipopeptides (CLPs) produced by the genus Bacillus are amphiphiles composed of hydrophilic amino acid and hydrophobic fatty acid moieties and are biosynthesised by non-ribosomal peptide synthetases (NRPSs). CLPs are produced as a mixture of homologues with different fatty acid moieties, whose length affects CLP activity. Iturin family lipopeptides are a family of CLPs comprising cyclic heptapeptides and β-amino fatty acids and have antimicrobial activity. There is little research on how the length of the fatty acid moiety of iturin family lipopeptides is determined. Here, we demonstrated that the acyl ligase (AL) domain determines the length of the fatty acid moiety in vivo. In addition, enzyme assays revealed how mutations in the substrate-binding pocket of the AL domain affected substrate specificity in vitro. Our findings have implications for the design of fatty acyl moieties for CLP synthesis using NRPS.

Antimicrobial Activity of Bacillus Cyclic Lipopeptides and Their Role in the Host Adaptive Response to Changes in Environmental Conditions

Bacillus cyclic lipopeptides (CLP), part of the three main families-surfactins, iturins, and fengycins-are secondary metabolites with a unique chemical structure that includes both peptide and lipid components. Being amphiphilic compounds, CLPs exhibit antimicrobial activity in vitro, damaging the membranes of microorganisms. However, the concentrations of CLPs used in vitro are difficult to achieve in natural conditions. Therefore, in a natural environment, alternative mechanisms of antimicrobial action by CLPs are more likely, such as inducing apoptosis in fungal cells, preventing microbial adhesion to the substrate, and promoting the death of phytopathogens by stimulating plant immune responses. In addition, CLPs in low concentrations act as signaling molecules of Bacillus's own metabolism, and when environmental conditions change, they form an adaptive response of the host bacterium. Namely, they trigger the differentiation of the bacterial population into various specialized cell types: competent cells, flagellated cells, matrix producers, and spores. In this review, we have summarized the current understanding of the antimicrobial action of Bacillus CLPs under both experimental and natural conditions. We have also shown the relationship between some regulatory pathways involved in CLP biosynthesis and bacterial cell differentiation, as well as the role of CLPs as signaling molecules that determine changes in the physiological state of Bacillus subpopulations in response to shifts in environmental conditions.

Glycolipid and Lipopeptide Biosurfactants: Structural Classes and Characterization-Rhamnolipids as a Model

In recent years, biosurfactants (BS) produced by various bacteria, fungi and yeast strains have attracted much interest because of their unique properties and potential applications in many industries ranging from bioremediation to agriculture and biomedical to cosmetics. Glycolipids are a popular group of BS that include rhamnolipids, sophorolipids, mannosylerythritol, trehalose lipids, xylolipids and cellobiose lipids. Lipopeptides e.g., surfactins, iturins and fengycins are of major biotechnological interest because of their antitumor, immunomodulatory, and antimicrobial activities effects. This review addresses the structural properties of glycolipids and lipopeptides, their main domains of application as well as the screening tests of BS production. Glycolipids are mostly composed of a carbohydrate moiety linked to a ß-hydroxy fatty acid chain with a glycosidic bond. The properties of glycolipids are related to the nature of the carbohydrate moiety and the length of the fatty acid chain. The lipopeptide structure is mainly composed of a linear or cyclic peptide linked to fatty acids of different chain lengths. The structural complexity of these compounds requires various analytical techniques for characterization and quantification. As an example, the analytical techniques used for the characterization of rhamnolipids are presented in this review. RLs are very promising BS with a wide range of applications in various fields, such as cosmetics, food science, pharmaceuticals, and environmental remediation.

Friends and Foes: Bacteria of the Hydroponic Plant Microbiome

Hydroponic greenhouses and vertical farms provide an alternative crop production strategy in regions that experience low temperatures, suboptimal sunlight, or inadequate soil quality. However, hydroponic systems are soilless and, therefore, have vastly different bacterial microbiota than plants grown in soil. This review highlights some of the most prevalent plant growth-promoting bacteria (PGPB) and destructive phytopathogenic bacteria that dominate hydroponic systems. A complete understanding of which bacteria increase hydroponic crop yields and ways to mitigate crop loss from disease are critical to advancing microbiome research. The section focussing on plant growth-promoting bacteria highlights putative biological pathways for growth promotion and evidence of increased crop productivity in hydroponic systems by these organisms. Seven genera are examined in detail, including Pseudomonas, Bacillus, Azospirillum, Azotobacter, Rhizobium, Paenibacillus, and Paraburkholderia. In contrast, the review of hydroponic phytopathogens explores the mechanisms of disease, studies of disease incidence in greenhouse crops, and disease control strategies. Economically relevant diseases caused by Xanthomonas, Erwinia, Agrobacterium, Ralstonia, Clavibacter, Pectobacterium, and Pseudomonas are discussed. The conditions that make Pseudomonas both a friend and a foe, depending on the species, environment, and gene expression, provide insights into the complexity of plant-bacterial interactions. By amalgamating information on both beneficial and pathogenic bacteria in hydroponics, researchers and greenhouse growers can be better informed on how bacteria impact modern crop production systems.

In Vitro Antagonistic Activity of Plant Growth Promoting Rhizobacteria Against Aggressive Biotypes of the Green Mold

During the cultivation of button mushrooms, the green mold epidemic, which causes a decrease in productivity, is a very important problem. The environmental harm of chemicals used in the control of such epidemics and the demand of consumers for organic products without chemicals have brought environmentally friendly biological control to the fore. Biological control can be achieved by the use of antagonistic microorganisms and their metabolites. In this study, the effectiveness of Bacillus spp. and Pseudomonas spp. for the biological control of the aggressive biotypes of the green mold disease agent Trichoderma aggressivum strains was examined in vitro. For this purpose, the antifungal effects of Bacillus spp. and Pseudomonas spp. against T. aggressivum strains were examined by in vitro dual culture test. Afterward, the antifungal activity of Bacillus spp. metabolites was assessed further using the agar well diffusion method. Then, it was determined whether the bacterial strains showing antifungal activity showed antagonistic activity against A. bisporus. Although none of the Pseudomonas spp. showed antifungal activity against T. aggressivum strains, most of the Bacillus spp. were found to have high activity. It has been concluded that Bacillus sp. Ö-4-82 may be potential biological control agent for button mushroom cultivation.

Insights into the antifungal mechanism of Bacillus subtilis cyclic lipopeptide iturin A mediated by potassium ion channel

Fungal infections pose severe and potentially lethal threats to plant, animal, and human health. Ergosterol has served as the primary target for developing antifungal medications. However, many antifungal drugs remain highly toxic to humans due to similarity in cell membrane composition between fungal and animal cells. Iturin A, lipopeptide produced by Bacillus subtilis, efficiently inhibit various fungi, but demonstrated safety in oral administration, indicating the existence of targets different from ergosterol. To pinpoint the exact antifungal target of iturin A, we used homologous recombination to knock out and overexpress erg3, a key gene in ergosterol synthesis. Saccharomyces cerevisiae and Aspergillus carbonarius were transformed using the LiAc/SS-DNNPEG and Agrobacterium-mediated transformation (AMT), respectively. Surprisingly, increasing ergosterol content did not augment antifungal activity. Furthermore, iturin A's antifungal activity against S. cerevisiae was reduced while it pre-incubation with voltage-gated potassium (Kv) channel inhibitor, indicating that Kv activation was responsible for cell death. Iturin A was found to activate the Kv protein, stimulating K+ efflux from cell. In vitro tests confirmed interaction between iturin A and Kv protein. This study highlights Kv as one of the precise targets of iturin A in its antifungal activity, offering a novel target for the development of antifungal medications.

Effects of branched-chain amino acids on surfactin structure and antibacterial activity in Bacillus velezensis YA215

Antibiotics are essential for combating pathogens; however, their misuse has led to increased resistance, necessitating the search for effective, low-toxicity alternatives. Surfactin, a cyclic lipopeptide with a C12-C17 β-hydroxy fatty acid chain, exhibits significant antibacterial activity and resists resistance, making it a research focus. Nonetheless, the effects of branched-chain amino acids (BCAAs) on surfactin's structure and activity are not well understood. This study examines the influence of BCAAs (L-valine, L-leucine, and L-isoleucine) on the lipopeptide (surfactin) produced by Bacillus velezensis YA215. Process optimization shows that adding 1 g/L of L-Leu and L-Ile, and 0.5 g/L of L-Val, maximized surfactin production to 18.59%, 19.23%, and 20.64%, respectively. Surfactin content peaked at 36 h with L-Val and L-Ile, yielding 19.72% and 11.37%. In contrast, L-Leu addition peaked at 24 h, yielding 11.33%. Notably, L-Val supplementation resulted in the highest relative surfactin content. Antimicrobial testing demonstrated that BCAAs significantly enhance the antibacterial effects of lipopeptides against Escherichia coli and Staphylococcus aureus, with Val showing the most pronounced effect. The addition of BCAAs notably altered the composition of surfactin fatty acid chains. Specifically, Val increased the proportions of iso C14 and iso C16 β-hydroxy fatty acids from 13.3% and 4.216-23.803% and 8.31%, respectively. Additionally, the amino acid composition at the 7th position of the peptide chain changed significantly, especially with Val addition, which increased the proportion of C14 [Val 7] surfactin by 3.29 times. These structural changes are likely associated with the enhanced antibacterial activity of surfactin. These findings provide valuable insights into the roles of BCAAs in microbial fermentation, underscoring their importance in metabolic engineering to enhance the production of bioactive compounds.

Total synthesis of antifungal lipopeptide iturin A analogues and evaluation of their bioactivity against F. graminearum

The pursuit of novel antifungal agents is imperative to tackle the threat of antifungal resistance, which poses major risks to both human health and to food security. Iturin A is a cyclic lipopeptide, produced by Bacillus sp., with pronounced antifungal properties against several pathogens. Its challenging synthesis, mainly due to the laborious synthesis of the β-amino fatty acid present in its structure, has hindered the study of its mode of action and the development of more potent analogues. In this work, a facile synthesis of bioactive iturin A analogues containing an alkylated cysteine residue is presented. Two analogues with opposite configurations of the alkylated cysteine residue were synthesized, to evaluate the role of the stereochemistry of the newly introduced amino acid on the bioactivity. Antifungal assays, conducted against F. graminearum, showed that the novel analogues are bioactive and can be used as a synthetic model for the design of new analogues and in structure-activity relationship studies. The assays also highlight the importance of the β-amino acid in the natural structure and the role of the stereochemistry of the amino fatty acid, as the analogue with the D configuration showed stronger antifungal properties than the one with the L configuration.

Microbial lipopeptides: their pharmaceutical and biotechnological potential, applications, and way forward

As lead molecules, cyclic lipopeptides with antibacterial, antifungal, and antiviral properties have garnered a lot of attention in recent years. Because of their potential, cyclic lipopeptides have earned recognition as a significant class of antimicrobial compounds with applications in pharmacology and biotechnology. These lipopeptides, often with biosurfactant properties, are amphiphilic, consisting of a hydrophilic moiety, like a carboxyl group, peptide backbone, or carbohydrates, and a hydrophobic moiety, mostly a fatty acid. Besides, several lipopeptides also have cationic groups that play an important role in biological activities. Antimicrobial lipopeptides can be considered as possible substitutes for antibiotics that are conventional to address the current drug-resistant issues as pharmaceutical industries modify the parent antibiotic molecules to render them more effective against antibiotic-resistant bacteria and fungi, leading to the development of more resistant microbial strains. Bacillus species produce lipopeptides, which are secondary metabolites that are amphiphilic and are typically synthesized by non-ribosomal peptide synthetases (NRPSs). They have been identified as potential biocontrol agents as they exhibit a broad spectrum of antimicrobial activity. A further benefit of lipopeptides is that they can be produced and purified biotechnologically or biochemically in a sustainable manner using readily available, affordable, renewable sources without harming the environment. In this review, we discuss the biochemical and functional characterization of antifungal lipopeptides, as well as their various modes of action, method of production and purification (in brief), and potential applications as novel antibiotic agents.